Dr.ReproEndo said:

Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 4.4% to 8.9% over 13 months.

Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:

The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.

pete_RVA said:

Fair, but phase 2 tolerability figures rarely survive contact with phase 3 scale.

Thank you for spelling out the reasoning rather than just the conclusion.

Dr.ReproEndo said:

Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 4.4% to 8.9% over 13 months.

I would rather people stopped quoting the 24% as if it were a licensed outcome. It is a phase 2 result in a few hundred participants with no cardiovascular endpoint and no long-term safety data, and this board has a habit of treating pipeline numbers as settled.

labquiet_amy said:

Triglycerides dropped by half, HDL barely moved, and my calculated LDL is almost exactly where it started, which is not the outcome I had been…

Before/after bloodwork compilation for the lipid panel — everything in one place for those who want comprehensive data:

Every single metabolic marker improved. This is why I'm a believer in this therapy.

Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.